Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CZ1S brachial plexus block for postoperative analgesia after arthroscopic rotator cuff repair (phase II)
CTR20250198Phase 2Completed
- Sponsor
- Zhejiang Cuize Pharmaceutical Technology
- Start
- Jan 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CZ1S in postoperative pain (2 arms), sponsored by Zhejiang Cuize Pharmaceutical Technology. Primary endpoint: Area under the curve of pain intensity at rest over 72 hours. Started Jan 2025; status: completed.
02
Drugs
CZ1S
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20250198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250198.